Eli Lilly (NYSE:LLY) announced today that it plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands. Located within the Leiden Bio Science Park, the new project aims to expand Lilly’s capacity to produce oral medicines. The company also hopes to strengthen its global supply chain with the new plant. Indianapolis-based Lilly…
Trelleborg opens expanded manufacturing facility in Massachusetts
Trelleborg has announced the grand opening of its expanded manufacturing facility and BioPharma Center of Excellence in Northborough, Massachusetts. The new facility for the Plymouth, Massachusetts-based company drives its strategy for growth in the biopharmaceutical industry. “Our expanded BioPharma Center of Excellence supports our goal of being the partner of choice for all leading biopharmaceutical…
Eli Lilly invests more than $1.2B in Puerto Rico plant
Eli Lilly (NYSE:LLY) announced today that it plans to invest more than $1.2 billion to expand and modernize a manufacturing site in Puerto Rico. The company plans to integrate advanced technologies and expand production capacity within the existing campus at its Lilly del Caribe plant in Carolina, Puerto Rico. It hopes to support its growing…
Merck breaks ground on new pharma manufacturing plant in Virginia
Merck (NYSE:MRK) announced today that it began construction on a new pharmaceutical manufacturing plant at its Elkton, Virginia, site. The company is investing $3 billion in the 400,000-square-foot facility. This comes as part of a commitment of more than $70 billion beginning this year to expand U.S. manufacturing and R&D. The company seeks to boost…
AbbVie invests $70M in U.S. biologics manufacturing, R&D expansion
AbbVie (NYSE:ABBV) announced that it began construction for a $70 million expansion of its bioresearch center (ABC) in Worcester, Massachusetts. The ABC in Worcester serves as a center of excellence for biologics R&D and manufacturing. AbbVie said its latest expansion comes as part of a plan to invest more than $10 billion in the U.S.…
Cardinal Health to build pharma distribution plant in Indianapolis
Cardinal Health (NYSE:CAH) today announced plans for a new flagship forward distribution center in Indianapolis. The new, state-of-the-art facility will further expand and modernize its national pharmaceutical distribution network. Dublin, Ohio-based Cardinal Health plans to include automation and the latest technology advancements in the new plant. It hopes to support the segment’s distribution of more…
Lilly to build new $6.5B API manufacturing plant in Texas
Eli Lilly (NYSE:LLY) announced today that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, Texas. The planned next-generation synthetic medicine active pharmaceutical product (API) facility marks the second of four new sites Lilly plans to announce this year. It follows the announcement of a $5 billion manufacturing facility…
Eli Lilly to build $5B manufacturing plant in Virginia
Eli Lilly (NYSE:LLY) announced today that it plans to build a $5 billion manufacturing facility in Goochland County, Virginia. The new site, just west of Richmond, will be the company’s first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly’s emerging bioconjugate platform and monocloncal antibody portfolio, according to a news…
Gilead breaks ground on California manufacturing hub
Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in…
Thermo Fisher completes acquisition of Sanofi’s fill-finish, packaging site in New Jersey
Thermo Fisher Scientific (NYSE:TMO) announced that it completed its acquisition of a Sanofi facility in New Jersey. The company acquired Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey. In July, the company announced its plans to acquire this site and continue producing a portfolio of Sanofi therapies there while opening the facility…